Read by QxMD icon Read

(mci OR alzhimer*) AND (sdb OR apnea OR OSA)

Mak Adam Daulatzai
Sporadic Alzheimer's disease (AD) is a devastating neurodegenerative disorder. It is essential to unravel its etiology and pathogenesis. This should enable us to study the presymptomatic stages of the disease and to analyze and reverse the antemortem behavioral, memory, and cognitive dysfunction. Prima facie, an ongoing chronic vulnerability involving neural insult may lead normal elderly to mild cognitive impairment (MCI) and then to AD. Development of effective preventive and therapeutic strategies to thwart the disease pathology obviously requires a thorough delineation of underlying disruptive neuropathological processes...
October 2016: Neurotoxicity Research
Michelle A Miller
It is becoming increasingly apparent that sleep plays an important role in the maintenance, disease prevention, repair, and restoration of both mind and body. The sleep and wake cycles are controlled by the pacemaker activity of the superchiasmic nucleus in the hypothalamus but can be disrupted by diseases of the nervous system causing disordered sleep. A lack of sleep has been associated with an increase in all-cause mortality. Likewise, sleep disturbances and sleep disorders may disrupt neuronal pathways and have an impact on neurological diseases...
2015: Frontiers in Neurology
Sophie Bayard
The mild cognitive impairment (MCI) is described as an intermediate state of cognitive impairment whereby individuals present with mild clinical symptoms but with nearly normal daily living activities. These subjects do not meet the clinical criteria for dementia, yet their cognitive functioning is below what we would expect for age and education in healthy people. In the other hand, older adults are at risk for sleep disorders including obstructive sleep apnea syndrome, restless legs syndrome, REM sleep behavioral disorder and chronic insomnia, which could have an impact on cognitive functioning and are exclusion criteria for the MCI diagnosis...
September 2015: Gériatrie et Psychologie Neuropsychiatrie du Vieillissement
Ricardo S Osorio, Tyler Gumb, Elizabeth Pirraglia, Andrew W Varga, Shou-En Lu, Jason Lim, Margaret E Wohlleber, Emma L Ducca, Viachaslau Koushyk, Lidia Glodzik, Lisa Mosconi, Indu Ayappa, David M Rapoport, Mony J de Leon
OBJECTIVE: To examine whether the presence of sleep-disordered breathing (SDB) is associated with an earlier age at mild cognitive impairment (MCI) or Alzheimer disease (AD)-dementia onset in participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. We also examined whether continuous positive airway pressure (CPAP) use is associated with delayed onset of cognitive decline. METHODS: From the ADNI cohort, 3 subsets with progressively stringent criteria were created in a step-wise manner...
May 12, 2015: Neurology
Laura Buratti, Simona Balestrini, Claudia Altamura, Giovanna Viticchi, Lorenzo Falsetti, Simona Luzzi, Leandro Provinciali, Fabrizio Vernieri, Mauro Silvestrini
BACKGROUND: Defining reliable markers of conversion to dementia could be the first step in order to identify appropriate treatment strategies for mild cognitive impairment (MCI) patients. OBJECTIVE: To develop a tool able to predict the risk of progression from MCI to Alzheimer's disease (AD). METHODS: 406 MCI patients were included and followed for a one-year period. Demographic characteristics, vascular risk factors, extent of cerebrovascular lesions, markers of carotid atherosclerosis investigated with an ultrasonographic assessment (plaque index and intima-media thickness) and cerebrovascular reactivity to apnea (breath-holding index) were considered as potential predictors of conversion...
2015: Journal of Alzheimer's Disease: JAD
Adam P Spira, Christopher Yager, Jason Brandt, Gwenn S Smith, Yun Zhou, Anil Mathur, Anil Kumar, James R Brašić, Dean F Wong, Mark N Wu
BACKGROUND/AIMS: Although disturbed sleep is associated with cognitive deficits, the association between sleep disturbance and Alzheimer's disease (AD) pathology is unclear. In this pilot study, we examined the extent to which sleep duration, sleep quality, and sleep-disordered breathing (SDB) are associated with β-amyloid (Aβ) deposition in the brains of living humans. METHODS: We studied 13 older adults (8 with normal cognition and 5 with mild cognitive impairment (MCI))...
August 12, 2014: SAGE Open Medicine
Edward F Pace-Schott, Rebecca M C Spencer
Sleep quality and architecture as well as sleep's homeostatic and circadian controls change with healthy aging. Changes include reductions in slow-wave sleep's (SWS) percent and spectral power in the sleep electroencephalogram (EEG), number and amplitude of sleep spindles, rapid eye movement (REM) density and the amplitude of circadian rhythms, as well as a phase advance (moved earlier in time) of the brain's circadian clock. With mild cognitive impairment (MCI) there are further reductions of sleep quality, SWS, spindles, and percent REM, all of which further diminish, along with a profound disruption of circadian rhythmicity, with the conversion to Alzheimer's disease (AD)...
2015: Current Topics in Behavioral Neurosciences
Martha Dlugaj, Gerhard Weinreich, Christian Weimar, Andreas Stang, Nico Dragano, Thomas E Wessendorf, Helmut Teschler, Angela Winkler, Natalia Wege, Susanne Moebus, Stefan Möhlenkamp, Raimund Erbel, Karl-Heinz Jöckel
There is increasing evidence that sleep disorders are associated with cognitive decline. We, therefore, examined the cross-sectional association of sleep-disordered breathing (SDB), sleep quality, and three types of sleep complaints (difficulties initiating sleep, difficulties maintaining sleep, and early morning awakening) with mild cognitive impairment (MCI) and its subtypes. A group of 1,793 participants (51% men; 63.8 ± 7.5 years) of the population-based Heinz Nixdorf Recall study (total sample n = 4,157) received a screening for SDB and self-report measures of sleep complaints...
2014: Journal of Alzheimer's Disease: JAD
Georgina Wilson, Zoe Terpening, Keith Wong, Ron Grunstein, Louisa Norrie, Simon J G Lewis, Sharon L Naismith
Purpose. Mild cognitive impairment (MCI) is considered an "at risk" state for dementia and efforts are needed to target modifiable risk factors, of which Obstructive sleep apnoea (OSA) is one. This study aims to evaluate the predictive utility of the multivariate apnoea prediction index (MAPI), a patient self-report survey, to assess OSA in MCI. Methods. Thirty-seven participants with MCI and 37 age-matched controls completed the MAPI and underwent polysomnography (PSG). Correlations were used to compare the MAPI and PSG measures including oxygen desaturation index and apnoea-hypopnoea index (AHI)...
2014: Sleep Disorders
C H Schenck, J Y Montplaisir, B Frauscher, B Hogl, J-F Gagnon, R Postuma, K Sonka, P Jennum, M Partinen, I Arnulf, V Cochen de Cock, Y Dauvilliers, P-H Luppi, A Heidbreder, G Mayer, F Sixel-Döring, C Trenkwalder, M Unger, P Young, Y K Wing, L Ferini-Strambi, R Ferri, G Plazzi, M Zucconi, Y Inoue, A Iranzo, J Santamaria, C Bassetti, J C Möller, B F Boeve, Y Y Lai, M Pavlova, C Saper, P Schmidt, J M Siegel, C Singer, E St Louis, A Videnovic, W Oertel
OBJECTIVES: We aimed to provide a consensus statement by the International Rapid Eye Movement Sleep Behavior Disorder Study Group (IRBD-SG) on devising controlled active treatment studies in rapid eye movement sleep behavior disorder (RBD) and devising studies of neuroprotection against Parkinson disease (PD) and related neurodegeneration in RBD. METHODS: The consensus statement was generated during the fourth IRBD-SG symposium in Marburg, Germany in 2011. The IRBD-SG identified essential methodologic components for a randomized trial in RBD, including potential screening and diagnostic criteria, inclusion and exclusion criteria, primary and secondary outcomes for symptomatic therapy trials (particularly for melatonin and clonazepam), and potential primary and secondary outcomes for eventual trials with disease-modifying and neuroprotective agents...
August 2013: Sleep Medicine
Seong Jae Kim, Jung Hie Lee, Dong Young Lee, Jin Hyoung Jhoo, Jong Inn Woo
OBJECTIVES: Sleep apnea syndrome (SAS) is considered a risk factor for cognitive decline in the elderly. The specific neurocognitive decline has been suggested as a predictive factor for dementia in patients with mild cognitive impairment (MCI). The authors aim to illustrate the sleep characteristics related to the specific neurocognitive decline in the community-dwelling elderly including patients with MCI. DESIGN: Cross-sectional. SETTINGS: Center for sleep and chronobiology in Kangwon National University Hospital...
April 2011: American Journal of Geriatric Psychiatry
S Bombois, P Derambure, F Pasquier, C Monaca
This paper reviews the characteristics of sleep disorders found in people at a greater risk of dementia: the elderly adult, patients with mild cognitive impairment (MCI) and those with neurodegenerative diseases. The frequency of sleep architecture modifications and circadian rhythm sleep disturbances increases with age. Although around 40% of older adults complain of poor sleep, true sleep disorders are far less prevalent in healthy older adults and are frequently associated with comorbidities. The sleep disorders observed in Alzheimer's disease (AD) patients are often similar to (but more intense than) those found in non-demented elderly people...
March 2010: Journal of Nutrition, Health & Aging
Annelies T Moerman, Luc L Herregods, Martine M De Vos, Eric P Mortier, Michel M R F Struys
BACKGROUND: The combination of propofol-remifentanil for procedural deep sedation in spontaneously breathing patients is characterized by the frequent incidence of side effects, especially respiratory depression. These side effects may be due to either the drug combination or the drug delivery technique. Target-controlled infusion (TCI) might optimize drug delivery. In this prospective, randomized, double-blind study in patients undergoing elective colonoscopy, we thus tried to answer two questions: first, if adding remifentanil to propofol surpasses the disadvantages of the combination of these two products, and second, if administration of remifentanil via TCI decreases the incidence of side effects, compared to manually controlled administration...
March 2009: Anesthesia and Analgesia
C Morigeri, A Bhattacharya, K Mukhopadhyay, A Narang, B R Mittal
PURPOSE: Gastroesophageal reflux (GER) is very common in pre-term infants. The diagnosis based on symptoms is always questionable. The incidence of GER in symptomatic babies varies from 22% to 85%, but literature regarding the incidence of reflux in asymptomatic pre-term infants is lacking. We used radionuclide scintigraphy to evaluate the incidence of GER in symptomatic as well as asymptomatic pre-term neonates and to assess whether symptoms have any relation with positive scintigraphy...
September 2008: European Journal of Nuclear Medicine and Molecular Imaging
G C Román
Ischemic or hemorrhagic cerebrovascular disease (CVD) produces injury of brain regions important for executive function, behavior, and memory leading to decline in cognitive functions and vascular dementia (VaD). Cardiovascular disease may cause VaD from hypoperfusion of susceptible brain areas. CVD may worsen degenerative dementias such as Alzheimer disease (AD). Currently, the global diagnostic category for cognitive impairment of vascular origin is vascular cognitive disorder (VCD). VCD ranges from vascular cognitive impairment (VCI) to VaD...
December 2004: Panminerva Medica
T Niethammer, G Del Fiore, J M Peters, D Lamotte, M Timsit-Berthier, L Quaglia, N Bougharouat, G Pozzessere
The synthesis of 13N-labelled nitrous oxide was made following NICKLES' method. After a partial denitrogenisation by breathing pure oxygen for 3 min, the subject inhaled a bolus of 13N-labelled nitrous oxide diluted in 2 l of oxygen (a mixture of 5% 13N2O and 95% O2). After an apnea of 30 sec the subject began to breathe in a closed respiratory system containing a mixture of 10% N2O and 90% O2. Eight images of the brain taken at level OM + 3 in 4 subjects showed an important uptake in the cerebellum and in the frontal and temporal cortex...
November 1982: Revue D'électroencéphalographie et de Neurophysiologie Clinique
C F Mackenzie, M Skacel, G M Barnas, W J Brampton, C A Alana
We evaluated the importance of cardiogenic gas mixing in the acini of 13 dogs during 2 min of apnea. 133Xe (1-2 mCi in 4 ml of saline) was injected into an alveolar region through an occluded pulmonary artery branch, and washout was measured by gamma scintillation scanning during continued occlusion or with blood flow reinstated. The monoexponential rate constant for Xe washout (XeW) was -0.4 +/- 0.08 (SE) min-1 at functional residual capacity (FRC) with no blood flow in the injected region. It decreased by more than half at lung volumes 500 ml above and 392 ml below FRC...
May 1990: Journal of Applied Physiology
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"